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ISSNObjectives: In Europe and elsewhere, health inequalities among HIV-positive individ-
uals are of concern. We investigated late HIV diagnosis and late initiation of combi-
nation antiretroviral therapy (cART) by educational level, a proxy of socioeconomic
position.
Design and methods: We used data from nine HIV cohorts within COHERE in Austria,
France, Greece, Italy, Spain and Switzerland, collecting data on level of education in
categories of the UNESCO/International Standard Classification of Education standard
classification: non-completed basic, basic, secondary and tertiary education. We
included individuals diagnosed with HIV between 1996 and 2011, aged at least
16 years, with known educational level and at least one CD4þ cell count within
6months of HIV diagnosis. We examined trends by education level in presentation with
advanced HIV disease (AHD) (CD4þ <200 cells/ml or AIDS within 6 months) using
logistic regression, and distribution of CD4þ cell count at cART initiation overall and
among presenters without AHD using median regression.
Results: Among 15414 individuals, 52, 45,37, and 31% with uncompleted basic,
basic, secondary and tertiary education, respectively, presented with AHD (P trend
<0.001). Compared to patients with tertiary education, adjusted odds ratios of AHD
were 1.72 (95% confidence interval 1.48–2.00) for uncompleted basic, 1.39
(1.24–1.56) for basic and 1.20 (1.08–1.34) for secondary education (P<0.001). In
unadjusted and adjusted analyses, median CD4þ cell count at cART initiation was
lower with poorer educational level.
Conclusions: Socioeconomic inequalities in delayed HIV diagnosis and initiation of
cART are present in European countries with universal healthcare systems and indi-
viduals with lower educational level do not equally benefit from timely cART initiation.
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2298 AIDS 2014, Vol 28 No 15European countries [6], a patient’s socioeconomic status
may influence the ease ordifficultyof access. Since the HIV
epidemic is entrenched among the socially vulnerable,
including homosexual men, injecting drug users (IDUs)
and migrants [7,8], with access to healthcare increasingly
limited for undocumented migrants [9,10], questions
about the effect of socio-economic status on the diagnosis
and treatment of HIV-positive persons are pressing.
Timely diagnosis of HIV infection is the first step in the
HIV treatment cascade, but the COHERE collaboration
of HIV cohorts of routine clinical practice in Europe
recently reported that there is a very high rate of late
presentation [11]. Those who do not know they have an
HIV infection are less likely to take steps to prevent its
transmission. Late diagnoses delay cART initiation and
raise the rates of hospitalization, morbidity and mortality
[12,13]. Universal access does not alone ensure that health
services will be utilized. Measuring socioeconomic status
is difficult. In adults, educational level is widely used as a
proxy given that it is fairly stable beyond early adulthood
and is therefore less likely to be affected by reverse
causation [14–17], that is, if the association between
socioeconomic status exists, because better health status
allows to achieve a better socioeconomic status. Previous
studies on the association between educational level, the
timing of HIV diagnosis and initiation of cART lack a
pan-European perspective to present a clear picture of the
problem [18–20]. These studies have been conducted in
single countries, each applying a different classification of
educational level. Without a clear understanding of the
role that socioeconomic inequality plays in access to HIV
diagnosis and treatment, we cannot formulate effective
policy and programs, or efficiently allocate resources,
particularly at times of economic crisis [21].
We investigated the association between socioeconomic
status and delayed HIV diagnosis and initiation of cART in
COHERE, a large European collaboration of HIV cohort
studies. We chose educational level as a proxy for
socioeconomic position and harmonized data on edu-
cation across cohorts. Our working hypothesis was that
lower educational level is linked to higher risk of delayed
diagnosis and cART initiation. Because of the widespread
practice of antenatal testing in the study setting and the
different testing strategies for the different HIV trans-
mission categories, our secondary aims were to examine
whether the association varied by sex and transmission
category.Methods
Patients
COHERE in EuroCoord is a collaboration of 35
observational cohorts covering 32 European countries,
within the framework of the EuroCoord network of
excellence (http://www.eurocoord.net). Each cohortpyright © Lippincott Williams & Wilkins. Unauthosubmits data in a standardized format (the HIV Collabo-
ration Data Exchange Protocol, http://www.hicdep.org)
to co-ordinating centres at the Copenhagen HIV
Programme, Denmark, or the Institut de Sante Publique
d’Epide´miologie et de De´veloppement (Bordeaux School
of Public Health), Bordeaux, France. The Regional
Coordinating Centres ensure adherence to strict quality
assurance guidelines and perform data checks, including
the removal of duplicate records. Data include information
on patients’ characteristics (age, sex, geographical origin,
and transmission category), use of cART (type of regimes
and dates of start and discontinuation), CD4þ cell counts
and plasma HIV-RNA over time and their dates, AIDS-
defining conditions and deaths. Further information is
available at www. cohere.org.
In 2012, EuroCoord defined socioeconomic variables
with the intent of standardizing and harmonizing
collection of socioeconomic data across cohorts in
European countries. Educational level was the only
available socioeconomic variable whose harmonization
across European countries could be performed retro-
spectively. The definition of the variable ‘maximum
attained level of education’ was based on the UNESCO/
International Standard Classification of Education
(ISCED) standard classification, and was classified as
‘uncompleted basic’ (ISCED 0), ‘basic’ (ISCED 1 and 2),
‘secondary’ (ISCED 3 and 4) and ‘tertiary’ (ISCED 5 and
6), based on data on education systems and reforms
available from the European Encyclopaedia on National
EducationSystems (http://eacea.ec.europa.eu/education/
eurydice/eurypedia_en.php).
These analyses included data from nine cohorts in six
European countries (Austria, France, Greece, Italy, Spain
and Switzerland) that collected data on maximum
attained educational level. Patients were included if they
were diagnosed with HIV between 1 January 1996 and 31
December 2011, were aged at least 16 years, were
enrolled within 6 months of HIV diagnosis, and had at
least one measured CD4þ cell count within 6 months of
their HIV diagnosis while cART-naive and the level of
education was known [11]. Patients from COHERE’s
three seroconverter cohorts were excluded; by definition,
they could not qualify as late presenters. Ethics approval
was granted by the Ethic Committees of each of the
participating cohorts according to country regulations.
Signed informed consent was obtained from all patients.
Data were pooled in September 2011 within COHERE
in EuroCoord (www.cohere.org and www.EuroCoord.
net) and additional data on educational level data were
received from the cohorts in 2012.
Statistical analyses
Delayed HIV presentation
We defined delayed HIV presentation based on
definitions proposed by the European Late Presenterrized reproduction of this article is prohibited.
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HIV disease (AHD) as CD4þ cell count below 200 cells/ml
or an AIDS-defining event in the 6 months following
presentation; and presentation with late HIV disease
(LHD) as CD4þ cell count below 350 cells/ml or an AIDS-
defining event in the 6 months following diagnosis [22].
We used logistic regression models to explore the
association between educational level with AHD and
LHD, adjusting for the following potential confounders,
chosen a priori: calendar period of HIV diagnosis (<2001
versus 2001, to reflect the introduction of optimal
cARTregimen, including boosted protease inhibitors and
non-nucleoside reverse transcriptase inhibitors); trans-
mission category (MSM, heterosexuals, IDUs, other/
unknown); geographical origin (Europe, non-European,
unknown); age at HIV diagnosis (<35 versus 35 years,
median age of the dataset); sex; and cohort. Likelihood
ratio tests were used to determine if sex and transmission
category were effect modifiers for the association
between educational level and delayed HIV diagnosis.
We also refit the models treating age at HIV diagnosis as a
continuous variable (linear and fractional polynomial
[23]), and, since the younger patients might not have
completed education yet, restricting to individuals with
age above 25 years. Finally, we described differences by
broad cohort geographical areas defined a priori as Austria,
France and Switzerland; and Greece, Italy and Spain.
These analyses were descriptive and not adjusted for
potential confounders. We present detailed results for the
AHD analyses and a summary of LHD analyses.
Because the analyses excluded patients with unknown
educational level and complete case analyses may be
biased if data on educational level are not missing
completely at random (MCAR), we used the following
sensitivity analyses. First, we used multiple imputation to
impute educational level [24] assuming data are missing at
random. After inspecting the characteristics of the
individuals with available and with missing data on level
of education, we decided to include in the imputation
model CD4þ cell count at HIV diagnosis in addition to all
variables used in the analysis models. Whereas age and
CD4þ cell count were treated as continuous variables, all
other variables were treated as categorical. Twenty
imputed data sets were generated, analysed separately
and then combined using Rubin’s rule [25]. Second, we
imputed missing data on educational level under the
assumption of data missing not at random and we assigned
all patients with unknown educational level to basic
education, secondary education and tertiary education in
separate analyses. These extreme case scenarios are
unrealistic in practice, but provide an illustration of
how sensitive the analyses may be to assumptions
regarding missing data. Since we excluded patients
without CD4þ cell count measured within 6 months
of HIV, we also ran analyses in which we assumed these
patients were all AHD and none AHD. Finally, weCopyright © Lippincott Williams & Wilkins. Unautreanalysed the data including patients who were enrolled
and had more than one CD4þ cell count within 3 months
and 12 months of HIV diagnosed rather than 6 months of
HIV diagnosis as in the main analysis.
CD4R cell count at initiation of antiretroviral therapy
We explored patterns of delayed cART initiation among
patients included in the analyses of delayed HIV diagnosis.
We further restricted the analysis to individuals who
initiated cART while cART-naive and who had their
CD4þ cell count measured at least once, between 6
months before and 1 week after cARTwas initiated. Tests
for trend and multiple median regression models
estimated the association between level of education
and CD4þ cell count at cART initiation overall and when
restricted to individuals who did not present with AHD.
All models were adjusted for sex, calendar year of cART
initiation, transmission category, geographical origin, age
at cART initiation, and cohort. Since there is no formal
definition of late cART initiation, and national and
international recommendations changed significantly
across the study period, we decided that analyses of the
distribution of CD4þ cell count at cART initiation with
median regression would return more interpretable and
robust results. As a sensitivity analysis, we defined late
cART initiation as individuals with a CD4þ cell count
below 350 cells/ml prior to initiation, and used logistic
regression models adjusting for the same covariates above.
Analyses were performed using Stata version 11.0 (Stata
Corp., College Station, Texas, USA).Results
Of the 37 438 patients diagnosed with HIV during 1996–
2011, 22 024 were excluded (12 656 enrolled >6 months
of HIV diagnosis; 2459 had no CD4þ cell count
measurements while cART-naive within 6 months of
HIV diagnosis; 6909 had unknown level of education).
Of the remaining 15 414 patients, 9, 28, 47 and 15% had
uncompleted basic, basic, secondary and tertiary edu-
cation. Compared to the excluded individuals, these were
more likely to be of European geographical origin,
infected through sex between men and diagnosed with
HIV after 2000. Median [interquartile range (IQR)]
CD4þ cell count and age at HIV diagnosis were 304
(125–503) cells/ml and 35 [29–43] years; 76% were men,
and 83% acquired HIV through heterosexual or MSM
contact. Proportions with uncompleted basic, basic,
secondary and tertiary education were 17, 39, 39 and 6%
for women and 7, 25, 50 and 18% for men.
Delayed diagnosis
A total of 6129 (40%) patients presented with AHD, of
which 5725 had CD4þ below 200 cells/ml, 404 had an
AIDS-defining event, and 2522 had both. The pro-
portion of AHD decreased with educational level: 52, 45,horized reproduction of this article is prohibited.
Co
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tertiary education (P for trend <0.001). Although the
proportion of patients presenting with AHD did not
differ for men and women (39 and 41%, respectively), the
proportion of AHD for uncompleted basic and tertiary
education varied more for men (54–30%) than for
women (49–41%) (P< 0.001 for interaction test). The
gradient was more pronounced after 2001 (P< 0.001 test
for interaction); the proportion of AHD with uncom-
pleted basic and tertiary education was 55 and 43% before
2001 and 50 and 28% from 2001 onwards (Table 1). The
gradient by educational level was more pronounced for
MSM compared to other groups; the proportion of AHD
ranged between 45 and 26% for patients with uncom-
pleted basic and tertiary education (Table 1). Gradients by
educational level varied by cohort, but were consistently
observed when data were grouped by broad geographical
regions, although more noticeable in Greece, Italy and
Spain (Table 1).
The gradient by educational level was maintained in
multivariate analyses; compared to tertiary education, the
adjusted odds ratios (aORs) for AHD were 1.72 [95%
confidence interval (CI) 1.48–2.00], 1.39 (95% CI 1.24–
1.56) and 1.20 (95% CI 1.08–1.34) in patients with
uncompleted basic, basic and secondary completed
education. In the adjusted logistic model, male sex,
calendar period of diagnosis 1996–2000, non-European
geographical origin, membership in the heterosexual and
injecting drug use transmission groups, and age above 35pyright © Lippincott Williams & Wilkins. Unautho
Table 1. Patient characteristics at HIV diagnosis and proportion who pres
and stratified by completed level of education.
Characteristics at HIV diagnosis N N with AHD %
Overall 15414 6129 40%
Sex
Male 11667 4591 39%
Female 3737 1538 41%
Calendar year
<2001 4763 2130 45%
2001 10651 3999 38%
Age (years)
>35 7436 3665 49%
35 7978 2464 31%
Geographical origin
European 11960 4691 39%
Non-European 2484 1093 44%
Unknown 970 345 35%
Transmission mode
MSM 6427 1995 31%
Heterosexual – men 3313 1675 51%
Heterosexual – women 3070 1259 41%
IDU – men 1299 584 45%
IDU – women 423 165 39%
Other/unknown – men 638 337 53%
Other/unknown – women 244 114 47%
European region of the cohort
Austria, France and Switzerland 3930 1384 35%
Greece, Italy and Spain 8508 3449 41%
COHERE in EuroCoord, 1996–2011. Advanced HIV disease: a CD4þ cell
following HIV diagnosis. AHD, advanced HIV disease; IDU, injecting druyears at HIV diagnosis were significant predictors of
presenting with AHD (data not shown).
Figure 1 shows the aOR for presentation with AHD and
sex-stratified educational level. The gradient by level of
education was more prominent in men (P value for
interaction 0.082). For instance, the aOR for uncom-
pleted basic education versus tertiary education was 1.70
(95% CI 1.41–2.04) in men and 1.31 (95% CI 0.96–1.82)
in women. The trend by educational level was maintained
restricting our analysis to MSM; aORs were 1.88 (95% CI
1.35–2.61), 1.67 (95% CI 1.40–1.99), and 1.27 (95% CI
1.10–1.46) compared to patients with tertiary education
(Table 2) (P value 0.225 for interaction test).
There were 9486 (62%) individuals with LHD at
presentation. Among patients with uncompleted basic,
basic, secondary and tertiary educational level, the
proportions of LHD were 73, 65, 59 and 55%. Trends
in proportion of LHD and aOR by level of education
were similar to the AHD analysis (Appendix 1, http://
links.lww.com/QAD/A557).
Sensitivity analyses
Individuals with unknown level of education had similar
demographic characteristics and similar proportions of
AHD and LHD, but were more likely to have an unknown
transmission mode and geographical origin (Appendix 2,
http://links.lww.com/QAD/A557). Results wererized reproduction of this article is prohibited.
ented with advanced HIV disease by baseline characteristics, overall
Proportion with AHD by completed level of education
Uncompleted basic Basic Secondary Tertiary
753 (52%) 1972 (45%) 2667 (37%) 737 (31%)
444 (54%) 1392 (48%) 2106 (36%) 649 (30%)
309 (49%) 580 (40%) 561 (39%) 88 (41%)
321 (55%) 614 (43%) 998 (43%) 197 (44%)
432 (50%) 1358 (46%) 1669 (34%) 540 (28%)
392 (59%) 1142 (56%) 1674 (47%) 457 (40%)
361 (46%) 830 (36%) 993 (27%) 280 (23%)
422 (52%) 1474 (46%) 2218 (37%) 577 (31%)
292 (52%) 349 (45%) 341 (41%) 111 (34%)
39 (43%) 149 (41%) 108 (32%) 49 (27%)
84 (45%) 394 (39%) 1090 (31%) 427 (26%)
221 (57%) 624 (55%) 682 (47%) 148 (46%)
252 (49%) 469 (40%) 465 (39%) 73 (39%)
86 (54%) 274 (45%) 204 (42%) 20 (49%)
22 (34%) 79 (40%) 61 (39%) 3 (75%)
53 (62%) 100 (62%) 130 (48%) 54 (45%)
35 (67%) 32 (41%) 35 (38%) 12 (55%)
133 (45%) 287 (41%) 836 (34%) 128 (28%)
445 (54%) 1443 (47%) 1079 (36%) 482 (30%)
count below 200cells/ml or an AIDS-defining event in the 6 months
g users.
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Fig. 1. Multivariate analyses of presentation with advanced HIV disease by sex. Estimates from multivariable logistic models
adjusted by transmission mode, geographical origin, age at HIV diagnosis, calendar period and cohort. Test for interaction:
P¼0.082. COHERE in EuroCoord, 1996–2011.consistent in all sensitivity analyses (Appendices 3 and 4,
http://links.lww.com/QAD/A557).
Delayed initiation of antiretroviral therapy
Of the 15414 individuals included in the previous
analysis, 72% (11 035) initiated cART. These patients
were mostly men (78%), MSM, had initiated cARTafter a
median (IQR) of 2 (1–7) months after HIV diagnosis
with a median (IQR) CD4þ cell count of 218 (90–331)
cells/ml and age 36 (31–42) years. Overall, results from
the median regression analyses indicate a strong
association between CD4þ cell count distribution at
cART initiation and educational level (P< 0.001
heterogeneity test). Notably, patients with uncompleted
basic, basic and secondary education had estimated
median CD4þ cell counts of 49, 27 and 19 cells/ml lower
than patients with tertiary education at the time of cART
initiation (Table 3). When the analyses were limited to the
5906 individuals who did not present with AHD, we
found a trend of lower CD4þ cell count with lower
educational level, but it was not statistically significant
(Table 4). The logistic regression analysis for late cART
initiation, defined as CD4þ cell count below 350 cells/ml,Copyright © Lippincott Williams & Wilkins. Unaut
Table 2. Multivariate analyses of presentation with advanced HIV diseas
MSM ID
Level of education N¼6427 N¼1
Uncompleted basic 1.88 (1.35,2.61) 1.20 (0.6
Basic 1.67 (1.40, 1.99) 0.93 (0.5
Secondary 1.27 (1.10,1.46) 0.99 (0.5
Tertiary 1 1
P<0.001 P¼0
Estimates from multivariable logistic models adjusted by sex, geographica
interaction: P¼0.225. COHERE in EuroCoord, 1996–2011. AHD, advancshowed a statistically significant association between
CD4þ cell count distribution at cART initiation and
educational level.Discussion
We found that in Europe in the cART era, individuals
with lower educational level were substantially more
likely to present with AHD and LHD, even after taking
into account individual characteristics that are tradition-
ally associated with delayed HIV diagnosis. This gradient
was more marked for men than for women. Among
patients who initiated cART, lower level of education was
independently associated with lower median CD4þ cell
count at cART initiation.
The mechanisms underlying the observed associations are
likely to implicate a number of material and psychosocial
pathways through which education influences attitudes
toward HIV testing and cART initiation. As a surrogate of
socioeconomic status, individuals with higher education
have better material resources such as employment andhorized reproduction of this article is prohibited.
e by transmission category.
U Heterosexual Other/unknown
722 N¼6383 N¼881
1,2.34) 1.39 (1.11,1.74) 1.64 (0.97,2.81)
0,1.74) 1.13 (0.92, 1.38) 1.02 (0.64,1.63)
2,1.87) 1.24 (1.10,1.39) 0.89 (0.58,1.36)
1 1
.472 P¼0.003 P¼0.073
l origin, age at HIV diagnosis, calendar period and cohort. Test for
ed HIV disease; IDU, injecting drug users.
Co
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Table 3. Distribution of CD4R at combination antiretroviral therapy initiation and multivariable analyses.
N
Median (IQR) CD4þ
cell count at cART
initiation
Proportion with
CD4þ <350
at cART
Multivariable analysis
Median regression Logistic regression
Median CD4þ
count (95% CI) P
Odds ratios for
CD4þ <350 at
cART (95% CI) P
Overall 11035 218 (90331) 78%
Baseline
231 (216248)
Level of education <0.001 <0.001
No basic 1036 173 (55294) 86% 49 (67, 30) 1.71 (1.36, 2.14)
Basic 3288 198 (70316) 82% 27 (41, 12) 1.23 (1.05, 1.45)
Secondary 5117 238 (101342) 77% 19 (32, 6) 1.07 (0.93, 1.24)
Tertiary 1594 251 (126345) 77% – 1
Estimates from multivariable median regression and logistic regression models adjusted by calendar period, sex, transmission mode, geographical
origin, age at cART initiation and cohort. COHERE in EuroCoord, 1996–2011. cART, combination antiretroviral therapy; CI, confidence interval;
IQR, interquantile range.higher-paying occupations [26], which imply easier
access to healthcare facilities. People with higher
education are more likely to practice health-promoting
behaviours, including timely healthcare check-ups and
screenings [27] and, therefore, might be more likely to
test for HIV when they perceive themselves at increased
risk. Higher education increases people’s health literacy
and cognitive skills, enabling them to make better
informed health-related choices [4,27], including the
importance of appropriate HIV testing and timely
initiation of cART with better access to websites and
community resources. Finally, education is linked with
social and psychological factors, including sense of
control, social standing and social support [26], and
individuals with higher education may face fewer barriers
to access HIV care and be more resilient to stigma [28].
Interestingly, the association between lower education
and lower CD4þ cell count at cART initiation was
substantially reduced though did not disappear, when the
analyses were restricted to individuals with timely HIV
diagnosis. Therefore, the observed association betweenpyright © Lippincott Williams & Wilkins. Unautho
Table 4. Distribution of CD4R cell count at combination antiretroviral th
who did not present with advanced HIV diagnosis.
N
Median (IQR) CD4þ
count at cART
initiation
Proportion with
CD4þ <350
at cART
Overall 5906 314 (250410) 62%
Level of education
No basic 441 305 (245399) 42%
Basic 1517 310 (246419) 36%
Secondary 2923 319 (250430) 38%
Tertiary 965 315 (256408) 37%
Estimates from multivariable regression and logistic regression models adju
age at cART initiation and cohort. COHERE in EuroCoord, 1996–2011. cA
interquantile range.delayed cART initiation and lower educational level
could be largely, but not solely, attributed to patterns of
delayed HIV diagnosis by educational level. This high-
lights the existence of additional socioeconomic barriers
that deter access to cART after HIV diagnosis.
The observed differences concord with previous evidence
from Spain and Italy indicating a higher frequency of
delayed HIV diagnosis and cART initiation among
individuals of lower educational level [19,20], and build
on previous work conducted within COHERE showing
very high levels of delayed HIV diagnoses in Europe [11].
We show in this study that not only presentation with
AHD and LHD is common across all educational level
groups, but that it exhibits an increasing trend with
decreasing educational levels. The gradient of the
association between level of education and delayed
diagnosis is more remarkable for AHD than for LHD.
Thus, socioeconomic inequalities are particularly visible
in patients with very low CD4þ cell count levels, usually
associated with high risk of AIDS and mortality [29].
These results are compatible with inequity in access torized reproduction of this article is prohibited.
erapy initiation and multivariable analyses restricting to individuals
Multivariable analysis
Median regression Logistic regression
Median CD4þ cell
count (95% CI) P
Odds ratios for
CD4þ <350 at
cART (95% CI) P
Baseline
312 (297326)
0.132 0.006
18 (34, 2) 1.44 (1.11, 1.88)
9 (21, 3) 1.12 (0.93, 1.35)
4 (14, 6) 0.99 (0.84, 1.16)
– 1
sted by calendar period, sex, transmission mode, geographical origin,
RT, combination antiretroviral therapy; CI, confidence interval; IQR,
Educational level and delayed HIV diagnosis Lodi et al. 2303HIV testing and are worrisome considering that the study
was conducted in six European countries with universal
public health systems.
The study shows that the association of delayed HIV
diagnosis with educational level differed between men
and women in absolute and relative terms. The milder
gradient in AHD by educational level observed in women
might be explained by universal HIV testing offered to all
pregnant women in European countries for prevention of
mother-to-child HIV transmission [30]. These findings,
however, need to be put in the context of the literature
that underlies that economic position may be a poorer
predictor for a number of health outcomes in women
[31]. The proportions of AHD for women from all four
educational levels are lower than those of the heterosexual
men but, compared to MSM, women with secondary and
tertiary education exhibit higher levels of AHD. MSM,
one of the key target groups for HIV screening in most
European countries [6], still had a steep decline in AHD
by educational level. These results indicate that universal
HIV screening approaches such as those aiming at all
pregnant women, as an alternative to targeted HIV testing
policies based on HIV risk perception such as those aimed
at MSM, could have the additional benefit to decrease
socioeconomic inequities in accessing HIV testing.
Whereas the former approach would offer a voluntary
HIV test to all pregnant women, for MSM to be offered
an HIV test, disclosure of unprotected sex with other men
and/or gay identity becomes a prerequisite which is likely
to be influenced by socioeconomic position [28,32].
For a long time, the interest to collect patient’s
socioeconomic information in HIV cohorts has been
rather limited, though some groups have strongly
promoted it [33]. The advantages of this study which
harmonized socioeconomic variables across several
cohorts in European countries are its large sample size,
allowing exploring interactions by sex and transmission
group, the inclusion of patients under routine care and its
standardised definition of the exposure variable across
European countries. The pan-European perspective of
the study suggests that the observed gradient of increased
risk of late HIV diagnosis and late cART initiation with
lower educational level is present across European
countries with different HIV healthcare and education
systems. The study also has some limitations. Not all
cohorts in COHERE collect data on educational level, so
this study was based on data from only six European
countries. Results thus might not be generalizable to
settings with different social systems such as those from
northern and eastern Europe. Some bias may have been
introduced through misclassification since an individual’s
educational level might not always reflect their socio-
economic status and whether this error is different for
men and women. In smaller-sized cohort studies,
combined indicators such as living on welfare, unstable
housing and unemployment were found to be associatedCopyright © Lippincott Williams & Wilkins. Unautwith non-adherence, whereas no association could be
found with each component alone [34]. Protopopescu
et al. have recently described how an indicator combining
low educational level and unemployment was found
associated with higher rates of mortality in the APROCO
cohort while none of each separate variable had a
significant effect [35]. However, educational level was the
only variable collected by the six participating cohorts
and it is important to note that education is one of the
most used measures of socioeconomic status in healthcare
research because of its influence on future occupational
opportunities and earning potential [14]. Foreigners
unfamiliar with the educational system of the host
country may have misreported their educational level.
However, these forms of misclassification are likely to be
non-differential, resulting in an underestimate of the
relationship between socioeconomic status and delayed
HIV diagnosis and cART initiation. Despite this potential
bias, we found significant trends and a clear gradient by
educational level, and we believe this strengthens, rather
than weakens, our conclusions about the existence of
socioeconomic inequalities. Finally, a number of indi-
viduals were excluded from the analyses because their
educational level was unknown or no CD4þ cell count
measurement was available at the time of HIV diagnosis.
Our estimates might be biased if the included and
excluded patients had a different distribution of
educational level and CD4þ cell count at HIV diagnosis.
Our conclusions were, however, robust to a set of
sensitivity analyses exploring different scenarios of
missing data mechanisms.
In conclusion, this study shows that inequalities by
educational level, a proxy of a socioeconomic status, in
HIV testing and initiation of cART are present in
European countries with universal healthcare systems,
and thus, individuals with lower educational level will not
equally benefit from the effectiveness of cART. Policies
and interventions that target socioeconomic determinants
leading to delays in HIV diagnosis and cART initiation
are needed. Whether the observed inequalities are all
avoidable, and thus amendable, is a discussion to be
urgently advanced within the equity policy framework
for Europe Health 2020 [36] and more deeply taken into
account in clinical and epidemiological research.
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